Navigation Links
Asymchem Announces Opening of High Potency API and Drug Product Facility
Date:5/20/2009

Facility Open as of May 1st, 2009 in TEDA Tianjin, China

TEDA Tianjin, China, May 20 /PRNewswire/ -- Asymchem Laboratories, Inc., a leading research-based contract manufacturer of API's and intermediates, and Drug Products to the pharmaceutical industry, is pleased to announce the opening if its high potency Active Pharmaceutical Ingredient (API) and Drug Product facility in TEDA Tianjin, China.

This dedicated facility is sited at Asymchem's TEDA Tianjin 1 location, and provides state-of-the art containment for production of potent API's, as well as tablet and capsule manufacturing that incorporate potent ingredients. The new facility allows Asymchem to operate two separate API manufacturing trains of 50 and 100L, as well as additional facilities for smaller-scale research and production and oral dosage form manufacturing.

"We are pleased to expand our capabilities in process research and manufacturing into the potent compound arena, and provide our partners with cost-effective and quality-driven means for undertaking this type of work in China," states Dr. Hao Hong, CEO of Asymchem.

Asymchem seeks to be a leader among Chinese-located manufacturing operations not only in facility design but also worker safety, and the Tianjin potent compound site was designed and validated by recognized and accredited experts in the potent compound community. As one of the largest and most respected pharmaceutical manufacturers in China, Asymchem is pleased to extend its broad range of API and drug product capabilities to this exciting and rapidly emerging field of drug research and development.

Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 14-yr track record, Asymchem is committed to th
'/>"/>

SOURCE Asymchem Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. TrinityCare Senior Living, Inc. Announces First Quarter Operating Results
2. SXC Health Solutions announces agreements for pharmacy technology services with Prime Therapeutics LLC
3. Recondo Technology Announces Two New Board Members
4. Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council
5. Cornerstone Therapeutics Announces Management Change
6. 3SBio Inc. Announces Unaudited First Quarter 2009 Results
7. Volcano Announces OCT Activities at EuroPCR 2009
8. International Isotopes Inc. Announces First Quarter 2009 Financial Results
9. LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital
10. Arcadia Resources Announces Sale of Non-Strategic Businesses
11. Fred A. Baughman Jr., MD Announces: Vets Sudden Cardiac Deaths Are Not Suicides or Overdoses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on ... Super Bowl. In the two weeks that separate the conference championships and the Super Bowl, ... Bowl game will mark the 50th time it has been held and the festivities will ...
(Date:7/31/2015)... ... July 31, 2015 , ... Last week, the Mesothelioma Applied ... can be accessed by visiting http://www.curemeso.org/store . , “Our new store features ... part: whenever a product is purchased, the Meso Foundation receives a $5.00 donation,” ...
(Date:7/31/2015)... FL (PRWEB) , ... July 31, 2015 , ... ... announced an important workshop at its new True North Conference Center. The medical ... so that the Jacksonville community may be more aligned in the effort to ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source ... to catch a new and refreshing show on Broadway, look no further than Hamilton. ... an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille Lortel Award, and ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... live lecture on pharmaceutical negligence is now available online at ( http://www.lawline.com/cle/course/its-a-wonderful-life-if-you-receive-the-right-meds-a-discussion-of-pharmaceutical-negligence ... with a 94% approval rating from the nationwide audience. The course ...
Breaking Medicine News(10 mins):Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2
... of septal malformation, researchers find , THURSDAY, Sept. ... during the first three months of pregnancy may have ... with heart defects. , Septal heart defects -- malformations ... heart from the left -- were more common among ...
... SAN FRANCISCO, CA SEPTEMER 24, 2009 Results ... that the combination of giving patients clopidogrel, a blood ... stomach medicines such as omeprazole, known as proton pump ... some prior studies had suggested. The results were presented ...
... WASHINGTON, Sept. 24 Clinic owners and operators Jose Martinez and ... to participating in a conspiracy to defraud the Medicare program, Assistant ... Terrence Berg of the Eastern District of Michigan and Daniel R. ... (HHS) announced. , , Jose Martinez, ...
... Unique database of agricultural pesticide application records informs research ... Northern California Cancer Center ( NCCC ... applied near their home may experience an increased risk of the most ... study, led by Rudolph Rull, Ph.D., used a database unique to California ...
... Sept. 24 A free "See, Test and Treat" ... & Wellness Center, the College of American Pathologists, and Susan G. ... the North Point Health and Wellness Center in Minneapolis, Minn. on ... a.m. to 3:30 p.m. each day by area community health representatives ...
... , , SAN FRANCISCO, Sept. ... leader in the development, manufacturing and sales of products for ... announced today imaging results from PROSPECT, the landmark 700 patient ... These data demonstrate the progression of cardiovascular disease via ...
Cached Medicine News:Health News:Antidepressants Linked to Heart Defects in Newborns 2Health News:Antidepressants Linked to Heart Defects in Newborns 3Health News:Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine 2Health News:Detroit Clinic Owner and Manager Plead Guilty to Medicare Fraud Charges 2Health News:Detroit Clinic Owner and Manager Plead Guilty to Medicare Fraud Charges 3Health News:Northern California Cancer Center Finds Increased Risk of Most Common Form of Childhood Leukemia Associated With Residential Proximity to Agricultural Pesticides 2Health News:Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 2Health News:Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 3Health News:Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 4Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 2Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 3Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 4Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 5Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 6Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 7
(Date:7/30/2015)... , July 30, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ ... into non-exclusive Development Agreements with Dexcom, Inc. to ... pumps with the Dexcom G5 and G6 continuous ... next generation pump platform with Dexcom,s future CGM ...
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today ... the second quarter ending June 30, 2015. ... organization.  We are excited to be near the completion ... conducted with topline results expected in the fourth quarter," ... Therapeutics, Inc. "Translarna is now commercially available in 12 ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10
... July 9 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... improvement in rheumatoid arthritis (RA) patients in the recently completed ... up to 6 months. The groups treated with 100 ... qd (once a day) reported higher ACR 20, ACR 50, ...
... , THOUSAND OAKS, Calif., July 7 Amgen (Nasdaq: ... Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic ... patients with advanced breast cancer met its primary and ... Superiority was demonstrated for both delaying the time ...
Cached Medicine Technology:Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 2Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 3Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 4Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 5Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 6Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 7Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 2Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 3Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 4Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 5Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 6Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 7Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 8
The 40D is ideal for pediatric ophthalmoscopy and other examinations requiring expansive fundus visibility. Alternatively, this lens may be used at the slit lamp biomicroscope to provide an extremely...
Provides exceptional resolution and fundus scanning capability. Excellent for small pupil diagnosis and treatment....
... Volks state-of-the-art 20D diagnostic/laser lens is ... aberrations and coma delivering the ... diopter lens on the market. Its ... linear image magnification and perfect image ...
The 15D provides high magnification along with an optimized working distance from the cornea. With its 4.11x magnification it is also well suited for disc and macular observation....
Medicine Products: